| EGLNX | SPMQX | EGLNX / SPMQX | |
| Total Expense Ratio | 1.26 | 8.68 | 15% |
| Annual Report Gross Expense Ratio | 1.67 | 8.68 | 19% |
| Fund Existence | 7 years | 7 years | - |
| Gain YTD | 3.351 | 6.174 | 54% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000000 | 1000000 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 212M | 3.88B | 5% |
| Annual Yield % from dividends | 4.96 | 7.26 | 68% |
| Returns for 1 year | 3.94 | 6.53 | 60% |
| Returns for 3 years | 71.47 | 60.89 | 117% |
| Returns for 5 years | 236.70 | 187.08 | 127% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MIOLX | 28.88 | 0.10 | +0.35% |
| Morgan Stanley Inst International Opp L | |||
| UBVUX | 78.41 | 0.18 | +0.23% |
| Undiscovered Managers Behavioral Val R4 | |||
| OILGX | 25.28 | 0.01 | +0.04% |
| Optimum Large Cap Growth Instl | |||
| SJGAX | 31.83 | N/A | N/A |
| Steward Large Cap Growth A | |||
| LYFCX | 15.64 | -0.10 | -0.64% |
| AlphaCentric Life Sciences & Hlthcare C | |||